L01XX Other antineoplastic agents

RX_L01XX

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L01XX

1289

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

1011

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

1011

diagram downward connector

Include endpoints None

1011

diagram downward connector
RX_L01XX

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
?
Number of individuals
979 465 514
?
Unadjusted prevalence (%)
0.32 0.27 0.38
?
Mean age at first event (years)
66.10 65.18 66.94

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.94 [3.41, 7.16] 2.9e-17 205
15 years 0.01 1.83 [1.23, 2.73] 2.9e-3 72
5 years 0.00 4.40 [3.02, 6.39] 8.9e-15 89
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits:

Survival analyses between endpoints

Plot

before L01XX Other antineoplastic agents
after L01XX Other antineoplastic agents

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L01XX Other antineoplastic agents